articleTop 10% cited

Surgery in Recurrent Ovarian Cancer: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial

Annals of Surgical Oncology · 2006 · Vol. 13(12) · pp. 1702–1710

Philipp Harter✉(Helios Dr. Horst Schmidt Kliniken Wiesbaden)Andreas du Bois(Helios Dr. Horst Schmidt Kliniken Wiesbaden)Maik Hahmann(Philipps University of Marburg)Annette Hasenburg(University of Freiburg)Alexander BurgesSibylle Loibl(Goethe University Frankfurt)M. Gropp(Hochschule Düsseldorf University of Applied Sciences)Jens Huober(University of Tübingen)Daniel FinkW. Schröder(Krankenhaus St. Joseph-Stift Bremen)Karsten Muenstedt(University of Giessen)Barbara SchmalfeldtGuenter Emons(University of Göttingen)Jacobus Pfisterer(University of Lübeck)K. Wollschlaeger(University Hospital Magdeburg)H.G. Meerpohl(St. Vincentius-Kliniken)G. P. Breitbach(City Hospital)Berno Tanner(University of Applied Sciences Mainz)Jalid Sehouli(Humboldt-Universität zu Berlin)

View via DOI Publisher page

Ovarian cancer diagnosis and treatment Intraperitoneal and Appendiceal Malignancies Endometrial and Cervical Cancer TreatmentsMedicineSurgical oncologyAscitesHazard ratioStage (stratigraphy)Ovarian cancerSurgeryCancerConfidence intervalGynecology

MeSH terms

AdultAgedAged, 80 and overFemaleHumansMiddle AgedNeoplasm Recurrence, LocalNeoplasms, Glandular and EpithelialOvarian NeoplasmsPrognosisGynecologic Surgical ProceduresSurvival RateNeoplasm, Residual

Citations

418

FWCI

12.85

field-weighted impact

References

Percentile

99%

vs. same field & year

Citations per year

Cited by

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials